INTRODUCTIONSTUDY GOALS AND OBJECTIVESBCC's goal in conducting this study was to understand the current status of the U.S. dermatological therapeutics industry and to assess it in the medium term from 2008 through 2013. We were particularly interested in understanding the future market potential for the current and emerging technologies and products within the dermatological therapeutics industry. This report assesses the available therapeutic procedures for skin, along with the drugs and technologies currently being used for various skin treatments. The role of public agencies, the regulatory environment, and non-governmental stakeholders has also been examined.REASONS FOR DOING THIS STUDYSkin disorders have a high active as well as passive morbidity in most human populations across the world. Yet, most dermatology manufacturers and dermatologists rely on cosmetic applications and procedures for survival.INTENDED AUDIENCEThis study is likely to be of interest to individuals and organizations involved in aspects of dermatological therapeutics industry, such as research, manufacturing and even large buyers in the industry. This report will also be of interest to manufacturers and marketers of dermatological therapeutics industry across the world.
1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Dermatological Therapeutics: Global Markets
Published on January 2009
Report Summary
INTRODUCTION
STUDY GOALS AND OBJECTIVES
BCC's goal in conducting this study was to understand the current status of the U.S. dermatological therapeutics industry and to
assess it in the medium term from 2008 through 2013. We were particularly interested in understanding the future market potential for
the current and emerging technologies and products within the dermatological therapeutics industry. This report assesses the
available therapeutic procedures for skin, along with the drugs and technologies currently being used for various skin treatments. The
role of public agencies, the regulatory environment, and non-governmental stakeholders has also been examined.
REASONS FOR DOING THIS STUDY
Skin disorders have a high active as well as passive morbidity in most human populations across the world. Yet, most dermatology
manufacturers and dermatologists rely on cosmetic applications and procedures for survival.
INTENDED AUDIENCE
This study is likely to be of interest to individuals and organizations involved in aspects of dermatological therapeutics industry, such
as research, manufacturing and even large buyers in the industry. This report will also be of interest to manufacturers and marketers
of dermatological therapeutics industry across the world.
Table of Content
CHAPTER ONE: INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THIS STUDY
INTENDED AUDIENCE
Dermatological Therapeutics: Global Markets Page 1/28
2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
SCOPE OF REPORT
METHODOLOGY
INFORMATION SOURCES
ABOUT THE AUTHOR
RELATED BCC RESEARCH REPORTS
BCC ONLINE SERVICES
DISCLAIMER
CHAPTER TWO: SUMMARY
SUMMARY TABLE GLOBAL DERMATOLOGICAL THERAPEUTICS REVENUE FORECAST BY MARKET SEGMENT, THROUGH
2013 ($ BILLIONS)
SUMMARY FIGURE GLOBAL DERMATOLOGICAL THERAPEUTICS REVENUE FORECAST BY MARKET SEGMENT, 2008 AND
2013 (%)
CHAPTER THREE: OVERVIEW
HUMAN SKIN
TABLE 1 FUNCTIONS OF THE SKIN
TABLE 1 (CONTINUED)
SKIN DISORDERS
TABLE 2 DISORDERS OF THE SKIN
TABLE 2 (CONTINUED)
TABLE 2 (CONTINUED)
TABLE 2 (CONTINUED)
ACNE
Dermatological Therapeutics: Global Markets Page 2/28
3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
TABLE 3 TYPES OF ACNE
ROSACEA
TABLE 4 TYPES OF ROSACEA
TABLE 5 DRUGS AND THEIR ACTION AGAINST ACNE AND ROSACEA
BACTERIAL INFECTIONS OF THE SKIN
TABLE 6 TYPES OF BACTERIAL INFECTIONS OF THE SKIN
TABLE 6 (CONTINUED)
TABLE 6 (CONTINUED)
TABLE 7 SOME PRESCRIPTION DRUGS PRESCRIBED TO TREAT BACTERIAL SKIN INFECTIONS
TABLE 7 (CONTINUED)
TABLE 7 (CONTINUED)
BENIGN SKIN GROWTHS OR TUMORS
TABLE 8 TYPES OF BENIGN SKIN GROWTHS OR TUMORS
TABLE 8 (CONTINUED)
TABLE 9 SOME PRESCRIPTION DRUGS USED TO TREAT BENIGN SKIN GROWTHS
TABLE 9 (CONTINUED)
BULLOUS DISORDERS OR BLISTERING DISEASES
TABLE 10 TYPES OF BULLOUS DISORDERS
TABLE 10 (CONTINUED)
TABLE 11 SOME PRESCRIPTION DRUGS USED TO TREAT BULLOUS SKIN DISORDERS
TABLE 11 (CONTINUED)
Dermatological Therapeutics: Global Markets Page 3/28
4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
SKIN CANCERS
TABLE 12 TYPES OF SKIN CANCERS
TABLE 12 (CONTINUED)
Types of Melanoma
Lentigo Maligna Melanoma
Superficial Spreading Melanoma
Nodular Melanoma
Acral-Lentiginous Melanoma
TABLE 13 SKIN CANCER INCIDENCE IN THE U.S
TABLE 14 SOME PRESCRIPTION DRUGS USED TO TREAT CUTANEOUS CARCINOMAS
CORNIFICATION DISORDERS
Calluses and Corns
TABLE 15 TYPES OF CALLUSES AND CORNS
Ichthyosis or Dry Skin
TABLE 16 TYPES OF ICHTHYOSIS
TABLE 16 (CONTINUED)
Keratosis Pilaris
TABLE 17 TYPES OF KERATOSIS PILARIS
Sebaceous Cysts
Dermatitis
Dermatological Therapeutics: Global Markets Page 4/28
5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
TABLE 18 TYPES OF DERMATITIS
TABLE 18 (CONTINUED)
TABLE 19 SOME DRUGS PRESCRIBED FOR DERMATITIS
Fungal Infections of the Skin
TABLE 20 TYPES OF FUNGAL INFECTIONS OF THE SKIN
TABLE 20 (CONTINUED)
TABLE 21 SOME DRUGS PRESCRIBED TO TREAT FUNGAL INFECTIONS OF THE SKIN
TABLE 21 (CONTINUED)
HYPERSENSITIVITY AND INFLAMMATORY DISORDERS
Acute Febrile Neutrophilic Dermatosis (Sweet's Syndrome)
Drug Eruptions and Reactions
TABLE 22 TYPES OF DRUG REACTIONS AND TYPICAL CAUSATIVE AGENTS
TABLE 22 (CONTINUED)
Erythema Multiforme
TABLE 23 TYPES OF ERYTHEMA MULTIFORME
Erythema Nodosum
Granuloma Annulare
Panniculitis
Pyoderma Gangrenosum
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Bed Sore
Pityriasis Rosea
Dermatological Therapeutics: Global Markets Page 5/28
6. Find Industry reports, Company profiles
ReportLinker and Market Statistics
TABLE 24 SOME DRUGS PRESCRIBED TO TREAT HYPERSENSITIVITY AND INFLAMMATORY DISORDERS
TABLE 24 (CONTINUED)
PARASITIC INFECTIONS OF THE SKIN
TABLE 25 TYPES OF PARASITIC INFECTION OF THE SKIN
TABLE 25 (CONTINUED)
TABLE 26 SOME DRUGS PRESCRIBED TO TREAT PARASITIC INFECTIONS OF THE SKIN
PSORIASIS AND SCALING DISEASES
TABLE 27 TYPES OF PSORIASIS AND SCALING DISEASES
Psoriasis Treatment
PIGMENTATION DISORDERS
TABLE 28 TYPES OF PIGMENTATION DISORDERS
Birthmarks
Poison Ivy
TABLE 29 SOME PRESCRIPTION DRUGS FOR PIGMENTATION DISORDERS
REACTIONS TO SUNLIGHT
Aging
Actinic Keratoses
Skin Cancers
Photosensitivity
TABLE 30 TYPES OF PHOTOSENSITIVITY
Dermatological Therapeutics: Global Markets Page 6/28
7. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Sunburn
SWEATING DISORDERS
TABLE 31 TYPES OF SWEATING DISORDERS
VIRAL SKIN DISEASES
TABLE 32 TYPES OF VIRAL SKIN DISEASES
TABLE 32 (CONTINUED)
TABLE 33 SOME DRUGS PRESCRIBED TO TREAT VIRAL DISEASES OF THE SKIN
TABLE 33 (CONTINUED)
COMMON DIAGNOSTIC TESTS FOR SKIN DISORDERS
DERMOSCOPY
PATCH TESTING
SKIN BIOPSY
CULTURE
PHOTOTESTS
MORBIDITY/PREVALENCE
TABLE 34 SKIN DISORDER MORBIDITY IN THE U.S. BY AGE AND CAUSE (THOUSANDS)
THERAPEUTIC PROCEDURES FOR THE SKIN
CANCER SURGERY
Excisional Biopsy to Remove Skin Cancer
Curettage and Electrocautery
Mohs Micrographic Surgery (MMS)
Wide Local Excision
Dermatological Therapeutics: Global Markets Page 7/28
8. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Skin Grafting
Lymph Node Removal
CHEMICAL PEELS
CRYOTHERAPY/CRYOSURGERY
Ice Packs
Cold Gel Packs
Ice Immersion
Ice Massage
Vapocoolant Sprays
RADIOTHERAPY
CHEMOTHERAPY
Chemotherapy Creams
Chemotherapy into a Vein
LASER SURGERY
TABLE 35 SKIN CONDITIONS REQUIRING ONLY LASER SURGERY
TABLE 35 (CONTINUED)
TABLE 35 (CONTINUED)
Carbon Dioxide Laser
YAG Laser
Pulsed Dye Laser or Argon Laser
Excimer Laser
TABLE 36 ADVANTAGES AND DISADVANTAGES OF EXCIMER LASER
PHOTODYNAMIC THERAPY
Dermatological Therapeutics: Global Markets Page 8/28
9. Find Industry reports, Company profiles
ReportLinker and Market Statistics
TABLE 37 VARIOUS CANCERS TREATABLE BY PDT
Application in Dermatology
TABLE 38 VARIOUS SKIN DISORDERS TREATABLE BY PDT
Goeckerman Treatment
PUVA
Ultraviolet B Phototherapy
Broadband
Narrowband
TABLE 39 ADVANTAGES AND DISADVANTAGES OF UVB THERAPY
SCLEROTHERAPY
CHAPTER FOUR: PRESCRIPTION DERMATOLOGICAL DRUGS
SYSTEMIC DRUGS
ACITRETIN
CLINDAMYCIN
ERYTHROMYCIN
CYCLOSPORINE
TABLE 40 ADVANTAGES AND DISADVANTAGES OF CYCLOSPORINE
METHOTREXATE
TABLE 41 ADVANTAGES AND DISADVANTAGES OF METHOTREXATE
THALIDOMIDE
SYSTEMIC ANTIBACTERIAL AGENTS
Dermatological Therapeutics: Global Markets Page 9/28
10. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Antileprotic Drugs (Including Dapsone)
Antimalarial Drugs (Including Hydroxychloroquine)
SYSTEMIC ANTIFUNGAL AGENTS
SYSTEMIC ANTIHISTAMINES
SYSTEMIC ANTIPARASITIC AGENTS
SYSTEMIC ANTIPRURITIC AGENTS
SYSTEMIC ANTIVIRAL AGENTS
SYSTEMIC CORTICOSTEROIDS
SYSTEMIC INTERFERONS
SYSTEMIC RETINOID
OTHER SYSTEMIC DRUGS
6-Thioguanine
Hydroxyurea
Mycophenolate Mofetil
Sulfasalazine
BIOLOGICAL THERAPIES (BIOLOGICS)
Colchicine
CYTOTOXIC AND IMMUNOSUPPRESSIVE DRUGS
Retinoids
Hormones and Anti-Androgens
Hormones and ' (Continued)
TOPICAL TREATMENTS
ACICLOVIR
TOPICAL RETINOIDS
ANTHRALIN
Dermatological Therapeutics: Global Markets Page 10/28
11. Find Industry reports, Company profiles
ReportLinker and Market Statistics
TABLE 42 ADVANTAGES AND DISADVANTAGES OF ANTHRALIN
COAL TAR
TABLE 43 ADVANTAGES AND DISADVANTAGES OF COAL TAR
CORTICOSTEROIDS
TABLE 44 ADVANTAGES AND DISADVANTAGES OF CORTICOSTEROIDS
TABLE 45 TOPICAL CORTICOSTEROIDS, 2004
TABLE 45 (CONTINUED)
TABLE 45 (CONTINUED)
RETINOID: TAZAROTENE
TABLE 46 ADVANTAGES AND DISADVANTAGES OF TAZAROTENE
VITAMIN D3: CALCIPOTRIENE
TABLE 47 ADVANTAGES AND DISADVANTAGES OF CALCIPOTRIOL
CAPSAICIN
TOPICAL MEDICATIONS IN CLINICAL TRIALS
MOISTURIZERS AND SCALE REMOVERS
TABLE 48 DRUG TREATMENTS FOR SKIN DISEASE INTRODUCED IN 2006
TABLE 48 (CONTINUED)
TABLE 48 (CONTINUED)
TABLE 48 (CONTINUED)
TABLE 48 (CONTINUED)
Dermatological Therapeutics: Global Markets Page 11/28
12. Find Industry reports, Company profiles
ReportLinker and Market Statistics
TABLE 48 (CONTINUED)
CHAPTER FIVE: TECHNOLOGY REVIEW
EMERGING TECHNOLOGIES IN DERMATOLOGY
DNA MICROARRAY TECHNOLOGY IN DERMATOLOGY
ADVANCES IN THE TREATMENT OF VARICOSE VEINS
EMERGING TREATMENT OF ATOPIC DERMATITIS
EMERGING DRUGS FOR ICHTHYOSIS
PROGRESS IN THE MANAGEMENT OF ACNE
PLASMA SKIN REGENERATION TECHNOLOGY
TABLE 49 NEW TECHNOLOGIES IN DERMATOLOGY
TABLE 49 (CONTINUED)
PERMEATION ENHANCEMENT TECHNOLOGIES
Drug Permeation Enhancement via Buccal Route
Thiomatrix: Permeation Enhancement
Merrion's Technology: Gastrointestinal Permeation Enhancement Technology (GIPET)
FIGURE 1 GASTROINTESTINAL PERMEATION ENHANCEMENT TECHNOLOGY
Transdermal Protein Delivery or Measurement Using Low-Frequency Sonophoresis
RADIOTHERAPY
External Radiotherapy
Conformal Radiotherapy
Intensity Modulated Radiotherapy
Internal Radiotherapy
Radioactive Implants
Dermatological Therapeutics: Global Markets Page 12/28
13. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Radioactive Liquids
Radioactive ' (Continued)
PLASMA SKIN REGENERATION
Plasma Skin ' (Continued)
Plasma Skin ' (Continued)
CHAPTER SIX: PATENT ANALYSIS
PATENT ISSUE TRENDS IN UNITED STATES
FIGURE 2 U.S. PATENT TRENDS, 1990-2001
TABLE 50 NUMBER OF U.S. PATENTS ISSUED, 2003 TO JULY 31, 2008
TABLE 51 COMPANIES AND NUMBER OF U.S. PATENTS FILED BY THEM, 2003 TO JULY 31, 2008
TABLE 52 RECENT DERMATOLOGY U.S. PATENTS
TABLE 52 (CONTINUED)
TABLE 52 (CONTINUED)
TABLE 52 (CONTINUED)
PATENT ISSUE TRENDS IN EUROPE
TABLE 53 EUROPEAN DERMATOLOGICAL PATENTS, 2003-JULY 2008.
TABLE 54 RECENT PATENTS ISSUED BY THE EPO
TABLE 54 (CONTINUED)
CHAPTER SEVEN: INDUSTRY PARTICIPANT PROFILES
MANUFACTURERS OF DERMATOLOGICAL DRUGS
AGI DERMATICS
ALLERGAN, INC
AMGEN, INC
Dermatological Therapeutics: Global Markets Page 13/28
14. Find Industry reports, Company profiles
ReportLinker and Market Statistics
ANACOR PHARMACEUTICALS
ANIKA THERAPEUTICS, INC
ASTELLAS US, LLC
CHESTER VALLEY PHARMACEUTICALS, INC
CORIA LABORATORIES, LTD
CORIA LABORATORIES, LTD
DERMIK LABORATORIES, INC
DUSA PHARMACEUTICALS, INC.
EISAI, INC.
FERNDALE LABORATORIES, INC.
GALDERMA LABORATORIES
GENENTECH, INC.
ISOLAGEN, INC.
LEO PHARMA A/S
MEDICIS PHARMACEUTICAL CORP
MEDIMETRIKS PHARMACEUTICALS, INC.
MERZ PHARMA UK, LTD.
NEOSIL, INC.
NYCOMED U.S., INC.
OBAGI MEDICAL PRODUCTS, INC.
ONSET THERAPEUTICS
ORTHONEUTROGENA
PIERRE FABRE PHARMACEUTICALS, INC
PRIME PHARMACEUTICALS CORP
QLT, INC.
Dermatological Therapeutics: Global Markets Page 14/28
15. Find Industry reports, Company profiles
ReportLinker and Market Statistics
QUINNOVA PHARMACEUTICALS
SCHERING-PLOUGH CORP
SINCLAIR PHARMACEUTICALS
SKINMEDICA, INC.
STIEFEL LABORATORIES, INC.
SUMMERS LABORATORIES, INC
SYNTOPIX GROUP, PLC
TRIAX PHARMACEUTICALS, LLC
VALEANT PHARMACEUTICALS INTERNATIONAL
VALEO PHARMA, INC.
WARNER CHILCOTT, LTD
XOMA, LTD
NON-COMMERCIAL ORGANIZATIONS
AFRICAN ASSOCIATION OF DERMATOLOGY
AMERICAN ACADEMY OF DERMATOLOGY (AAD)
AMERICAN BEHCET'S DISEASE ASSOC., INC
AMERICAN CELIAC SOCIETY
AMERICAN HEMOCHROMATOSIS SOCIETY, INC
AMERICAN LUPUS SOCIETY
AMERICAN SKIN ASSOCIATION, INC
AMERICAN SOCIAL HEALTH ASSOC
ARTHRITIS FOUNDATION
ASIAN DERMATOLOGICAL ASSOCIATION
ASSOCIATION OF PROFESSORS OF DERMATOLOGY
ATAXIA-TELANGIECTASIA CHILDREN'S PROJECT
Dermatological Therapeutics: Global Markets Page 15/28
16. Find Industry reports, Company profiles
ReportLinker and Market Statistics
BASAL CELL CARCINOMA NEVUS SYNDROME/GORLIN SYNDROME
BAY AREA LUPUS FOUNDATION
BLOOM'S SYNDROME REGISTRY
BRITISH ASSOCIATION OF DERMATOLOGISTS
CELIAC DISEASE FOUNDATION
CELIAC SPRUE ASSOCIATION/USA
CICATRICIAL ALOPECIA RESEARCH FOUNDATION
COALITION OF SKIN DISEASES
CORNELIA DE LANGE SYNDROME FOUNDATION, INC
CUTANEOUS LYMPHOMA FOUNDATION
DERMATOLOGY FOUNDATION
DERMATOLOGY NURSES ASSOCIATION (DNA)
DERMATOPATHOLOGY FOUNDATION
DYSAUTONOMIA FOUNDATION, INC
DYSTROPHIC EPIDERMOLYSIS BULLOSA
THE ECTODERMAL DYSPLASIA SOCIETY
EHLERS DANLOS NATIONAL FOUNDATION (EDNF)
EHLERS-DANLOS SYNDROME FOUNDATION
EUROPEAN ACADEMY FOR DERMATOLOGY AND VENEREOLOGY
EADV Administrative Office
THE EUROPEAN DERMATOLOGY FORUM
EUROPEAN SOCIETY FOR DERMATOLOGICAL RESEARCH
EUROPEAN UNION OF MEDICAL SPECIALISTS
FOUNDATION FOR ICHTHYOSIS AND RELATED SKIN TYPES
(F.I.R.S.T.)
Dermatological Therapeutics: Global Markets Page 16/28
17. Find Industry reports, Company profiles
ReportLinker and Market Statistics
GLUTEN INTOLERANCE GROUP (DERMATITIS HERPETIFORMIS)
HEMOCHROMATOSIS RESEARCH FOUNDATION
HIDRADENITIS SUPPURATIVA FOUNDATION, INC
HISTIOCYTOSIS ASSOCIATION OF AMERICA
INFLAMMATORY SKIN DISEASE INSTITUTE (ISDI)
INTERNATIONAL FOUNDATION FOR DERMATOLOGY
THE INTERNATIONAL LEAGUE OF DERMATOLOGICAL SOCIETIES OFFICE
INTERNATIONAL PEMPHIGUS PEMPHIGOID FOUNDATION
THE INTERNATIONAL SOCIETY OF DERMATOPATHOLOGY
KLIPPEL-TRENAUNAY SUPPORT GROUP
LUPUS FOUNDATION OF AMERICA, INC.
LYMPHOMA RESEARCH FOUNDATION
LYMPHOMATOID PAPULOSIS CENTRAL REGISTRY
MARFAN ASSOC. U.K.
THE MELANOMA RESEARCH FOUNDATION
MUSCULAR DYSTROPHY ASSOC
MYOSITIS ASSOCIATION OF AMERICA (MAA)
NATIONAL ALOPECIA AREATA FOUNDATION (NAAF)
NATIONAL ATAXIA FOUNDATION
NATIONAL ECZEMA ASSOCIATION (NEA)
NATIONAL ECZEMA ASSOCIATION FOR SCIENCE AND EDUCATION
NATIONAL ECZEMA SOCIETY
NATIONAL EPIDERMOLYSIS BULLOSA REGISTRY
NATIONAL FOUNDATION FOR ECTODERMAL DYSPLASIAS
NATIONAL FOUNDATION FOR VITILIGO AND PIGMENT DISORDERS
Dermatological Therapeutics: Global Markets Page 17/28
18. Find Industry reports, Company profiles
ReportLinker and Market Statistics
NATIONAL INCONITENTIA PIGMENTI FOUNDATION
NATIONAL MEDICAL ASSOC
NATIONAL NEUROFIBROMATOSIS FOUNDATION
NATIONAL ORGANIZATION FOR ALBINISM AND HYPOPIGMENTATION (NOAH)
NATIONAL ORGANIZATION FOR RARE DISORDERS (NORD)
THE NATIONAL PEMPHIGUS FOUNDATION
NATIONAL PSORIASIS FOUNDATION
NATIONAL REGISTRY FOR ICHTHYOSIS AND RELATED DISORDERS
NATIONAL VITILIGO FOUNDATION
NEVOID BASAL CELL CARCINOMA SYNDROME SUPPORT NETWORK
PACHYONYCHIA CONGENITA PROJECT
THE PSORIASIS ASSOC.
SCLERODERMA FEDERATION, INC
SCLERODERMA FOUNDATION
SCLERODERMA RESEARCH FOUNDATION
THE SCLERODERMA SOCIETY
SOCIETY FOR INVESTIGATIVE DERMATOLOGY (SID)
SOCIETY FOR PEDIATRIC DERMATOLOGY (SPD)
THE STURGE-WEBER FOUNDATION
THE VITILIGO SOCIETY, U.K.
VITILIGO SUPPORT INTERNATIONAL
VZV RESEARCH FOUNDATION
XERODERMA PIGMENTOSUM SOCIETY
TABLE 55 DERMATOLOGICAL ASSOCIATIONS
Dermatological Therapeutics: Global Markets Page 18/28
19. Find Industry reports, Company profiles
ReportLinker and Market Statistics
TABLE 55 (CONTINUED)
STRATEGIC ALLIANCES IN THE DERMATOLOGY MARKET
MERGERS & ACQUISITIONS
TABLE 56 SIGNIFICANT MERGERS AND ACQUISITIONS (2005-2008)
TABLE 56 (CONTINUED)
TABLE 56 (CONTINUED)
VENTURE CAPITAL DEALS
CHAPTER EIGHT: REGULATORY PREVIEW
DRUG REGULATION IN THE UNITED STATES
LICENSES FOR MEDICAL DEVICES
DRUG REGULATION IN THE UNITED KINGDOM
LICENSES FOR DRUGS
DRUG AND EQUIPMENT APPROVAL IN EUROPE
LICENSES FOR MEDICAL EQUIPMENT
REIMBURSEMENT FOR DERMATOLOGICAL TREATMENT
REIMBURSEMENT IN THE UNITED STATES
REIMBURSEMENT IN EUROPE
Reimbursement in Europe (Continued)
CHAPTER NINE: MARKET METRICS
MARKET TRENDS
BIG PHARMA'S FOCUS ON BLOCKBUSTER DRUGS ENABLES SPECIALTY FOCUS BY SMALL AND MEDIUM-SIZED FIRMS
COSMETIC/AESTHETIC DERMATOLOGY FACES DOWNTURN
CHANGES IN REIMBURSEMENT AND OTHER LEGISLATION ARE CREATING UNCERTAINTY
Managed Care Issues
Dermatological Therapeutics: Global Markets Page 19/28
20. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Medical Liability
Physician Quality Reporting Initiative (PQRI)
Dermatologic Surgery
Cosmetic Procedure Tax
INCREASED USE OF GENERICS IN PRESCRIPTION DERMATOLOGY
DIFFICULTIES IN DETERMINATION OF BIOAVAILABILITY OF TOPICAL DRUGS
PHYSICIAN SHORTAGE AND PARAMEDIC INFLUX IN DERMATOLOGY
CERTIFICATION EXAM FOR NURSE PRACTITIONERS IN DERMATOLOGY NOW AVAILABLE
USE OF PROCEDURE-THERAPY AND SPECIFIC DRUGS IN DERMATOLOGY
POLLUTION CONTRIBUTES TO RISE IN ATOPIC DERMATITIS
MANUFACTURERS OF TNF-BLOCKER DRUGS ORDERED TO HIGHLIGHT RISK OF FUNGAL INFECTIONS
HIGHER CO-PAYS FOR BIOLOGICS IMPACTS PRESCRIPTIONS
U.S. DERMATOLOGICAL MARKET
TABLE 57 LEADING DRUGS PRESCRIBED BY OFFICE-BASED DERMATOLOGISTS'ALL INDICATIONS, 2008 (THOUSANDS)
PRESCRIPTION DATA FOR ACNE
Prescription Data for Acne (Continued)
FIGURE 3 PRESCRIBING OF ORAL ANTIBIOTICS FOR THE INTITIAL TREATMENT OF ACNE: CURRENT AND IN 1 YEAR
(N=75)
FIGURE 4 PRESCRIBING OF TOPICAL ANTIBIOTICS/RETINOIDS FOR ACNE: CURRENT AND IN 1 YEAR (N=75)
TABLE 58 U.S. DERMATOLOGICAL THERAPEUTICS MARKET: REVENUE FORECAST BY MARKET SEGMENT, THROUGH
2013 ($BILLIONS)
FIGURE 5 SHARE OF SEGMENTS IN U.S. PRESCRIPTION DERMATOLOGY MARKET, 2008 AND 2013 (%)
FIGURE 5 (CONTINUED)
FIGURE 6 LEADING PRESCRIPTION DRUG REVENUES IN GLOBAL DERMATOLOGY MARKET, 2008 ($ MILLIONS)
Dermatological Therapeutics: Global Markets Page 20/28
21. Find Industry reports, Company profiles
ReportLinker and Market Statistics
FIGURE 6 (CONTINUED)
ENBREL
FIGURE 7 ENBREL SALES IN GLOBAL DERMATOLOGY MARKET BY GEOGRAPHY, 2008 (%, TOTAL REVENUE = $ 3,230
MILLION)
BOTOX
FIGURE 8 BOTOX SALES IN THE GLOBAL DERMATOLOGY MARKET BY GEOGRAPHY, 2008 (%, TOTAL REVENUE = $ 1,200
MILLION
FIGURE 8 (CONTINUED)
LOCERYL
FIGURE 9 LOCERYL SALES IN GLOBAL DERMATOLOGY MARKET BY GEOGRAPHY, 2008 (%, TOTAL = $350 MILLION
FIGURE 10 GLOBAL DERMATOLOGICAL PRESCRIPTION MARKET BY REGIONAL SHARE'FUTURE OUTLOOK, 2011 (%)
TABLE 59 MARKET SHARE OF PRESCRIPTION DRUG MANUFACTURERS, 2005-2007 ($ MILLIONS)
GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET
FIGURE 11 GLOBAL DERMATOLOGICAL MARKET BY REGIONAL SHARE, 2008 (%)
TABLE 60 GLOBAL DERMATOLOGICAL THERAPEUTICS REVENUE FORECAST BY MARKET SEGMENT, THROUGH 2013
FIGURE 12 GLOBAL PRESCRIPTION DERMATOLOGY MARKET SHARE BY SEGMENT, 2008 (%)
FIGURE 12 (CONTINUED)
GLOBAL DERMATOLOGICAL ' (CONTINUED)
GLOBAL DERMATOLOGICAL ' (CONTINUED)
LIST OF TABLES
SUMMARY TABLE GLOBAL DERMATOLOGICAL THERAPEUTICS
REVENUE FORECAST BY MARKET SEGMENT, THROUGH 2013
Dermatological Therapeutics: Global Markets Page 21/28
22. Find Industry reports, Company profiles
ReportLinker and Market Statistics
($ BILLIONS)
TABLE 1 FUNCTIONS OF THE SKIN
TABLE 2 DISORDERS OF THE SKIN
TABLE 3 TYPES OF ACNE
TABLE 4 TYPES OF ROSACEA
TABLE 5 DRUGS AND THEIR ACTION AGAINST ACNE AND ROSACEA
TABLE 6 TYPES OF BACTERIAL INFECTIONS OF THE SKIN
TABLE 7 SOME PRESCRIPTION DRUGS PRESCRIBED TO
TREAT BACTERIAL SKIN INFECTIONS
TABLE 8 TYPES OF BENIGN SKIN GROWTHS OR TUMORS
TABLE 9 SOME PRESCRIPTION DRUGS USED TO TREAT
BENIGN SKIN GROWTHS
TABLE 10 TYPES OF BULLOUS DISORDERS
TABLE 11 SOME PRESCRIPTION DRUGS USED TO TREAT
BULLOUS SKIN DISORDERS
TABLE 12 TYPES OF SKIN CANCERS
TABLE 13 SKIN CANCER INCIDENCE IN THE U.S.
TABLE 14 SOME PRESCRIPTION DRUGS USED TO TREAT
CUTANEOUS CARCINOMAS
TABLE 15 TYPES OF CALLUSES AND CORNS
TABLE 16 TYPES OF ICHTHYOSIS
TABLE 17 TYPES OF KERATOSIS PILARIS
TABLE 18 TYPES OF DERMATITIS
TABLE 19 SOME DRUGS PRESCRIBED FOR DERMATITIS
TABLE 20 TYPES OF FUNGAL INFECTIONS OF THE SKIN
Dermatological Therapeutics: Global Markets Page 22/28
23. Find Industry reports, Company profiles
ReportLinker and Market Statistics
TABLE 21 SOME DRUGS PRESCRIBED TO TREAT FUNGAL
INFECTIONS OF THE SKIN
TABLE 22 TYPES OF DRUG REACTIONS AND TYPICAL
CAUSATIVE AGENTS
TABLE 23 TYPES OF ERYTHEMA MULTIFORME
TABLE 24 SOME DRUGS PRESCRIBED TO TREAT
HYPERSENSITIVITY AND INFLAMMATORY DISORDERS
TABLE 25 TYPES OF PARASITIC INFECTION OF THE SKIN
TABLE 26 SOME DRUGS PRESCRIBED TO TREAT PARASITIC
INFECTIONS OF THE SKIN
TABLE 27 TYPES OF PSORIASIS AND SCALING DISEASES
TABLE 28 TYPES OF PIGMENTATION DISORDERS
TABLE 29 SOME PRESCRIPTION DRUGS FOR PIGMENTATION
DISORDERS
TABLE 30 TYPES OF PHOTOSENSITIVITY
TABLE 31 TYPES OF SWEATING DISORDERS
TABLE 32 TYPES OF VIRAL SKIN DISEASES
TABLE 33 SOME DRUGS PRESCRIBED TO TREAT VIRAL DISEASES OF
THE SKIN
TABLE 34 SKIN DISORDER MORBIDITY IN THE U.S. BY AGE AND
CAUSE (THOUSANDS)
TABLE 35 SKIN CONDITIONS REQUIRING ONLY LASER SURGERY
TABLE 36 ADVANTAGES AND DISADVANTAGES OF EXCIMER LASER
TABLE 37 VARIOUS CANCERS TREATABLE BY PDT
TABLE 38 VARIOUS SKIN DISORDERS TREATABLE BY PDT
Dermatological Therapeutics: Global Markets Page 23/28
24. Find Industry reports, Company profiles
ReportLinker and Market Statistics
TABLE 39 ADVANTAGES AND DISADVANTAGES OF UVB THERAPY
TABLE 40 ADVANTAGES AND DISADVANTAGES OF CYCLOSPORINE
TABLE 41 ADVANTAGES AND DISADVANTAGES OF METHOTREXATE
TABLE 42 ADVANTAGES AND DISADVANTAGES OF ANTHRALIN
TABLE 43 ADVANTAGES AND DISADVANTAGES OF COAL TAR
TABLE 44 ADVANTAGES AND DISADVANTAGES OF
CORTICOSTEROIDS
TABLE 45 TOPICAL CORTICOSTEROIDS, 2004
TABLE 46 ADVANTAGES AND DISADVANTAGES OF
TAZAROTENE
TABLE 47 ADVANTAGES AND DISADVANTAGES OF CALCIPOTRIOL
TABLE 48 DRUG TREATMENTS FOR SKIN DISEASE
INTRODUCED IN 2006
TABLE 49 NEW TECHNOLOGIES IN DERMATOLOGY
TABLE 50 NUMBER OF U.S. PATENTS ISSUED, 2003 TO
JULY 31, 2008
TABLE 51 COMPANIES AND NUMBER OF U.S. PATENTS FILED BY
THEM, 2003 TO JULY 31, 2008
TABLE 52 RECENT DERMATOLOGY U.S. PATENTS
TABLE 53 EUROPEAN DERMATOLOGICAL PATENTS, 2003-JULY 2008
TABLE 54 RECENT PATENTS ISSUED BY THE EPO
TABLE 55 DERMATOLOGICAL ASSOCIATIONS
TABLE 56 SIGNIFICANT MERGERS AND ACQUISITIONS (2005-2008)
TABLE 57 LEADING DRUGS PRESCRIBED BY OFFICE-BASED
DERMATOLOGISTS'ALL INDICATIONS, 2008 (THOUSANDS)
Dermatological Therapeutics: Global Markets Page 24/28
25. Find Industry reports, Company profiles
ReportLinker and Market Statistics
TABLE 58 U.S. DERMATOLOGICAL THERAPEUTICS MARKET:
REVENUE FORECAST BY MARKET SEGMENT, THROUGH 2013
($ BILLIONS)
TABLE 59 MARKET SHARE OF PRESCRIPTION DRUG
MANUFACTURERS, 2005-2007 ($ MILLIONS)
TABLE 60 GLOBAL DERMATOLOGICAL THERAPEUTICS REVENUE
FORECAST BY MARKET SEGMENT, THROUGH 2013
LIST OF FIGURES
SUMMARY FIGURE GLOBAL DERMATOLOGICAL THERAPEUTICS
REVENUE FORECAST BY MARKET SEGMENT, 2008 AND 2013 (%)
FIGURE 1 GASTROINTESTINAL PERMEATION ENHANCEMENT
TECHNOLOGY
FIGURE 2 U.S. PATENT TRENDS, 1990-2001
FIGURE 3 PRESCRIBING OF ORAL ANTIBIOTICS FOR THE INTITIAL
TREATMENT OF ACNE: CURRENT AND IN 1 YEAR (N=75)
FIGURE 4 PRESCRIBING OF TOPICAL ANTIBIOTICS/RETINOIDS FOR
ACNE: CURRENT AND IN 1 YEAR (N=75)
FIGURE 5 SHARE OF SEGMENTS IN U.S. PRESCRIPTION
DERMATOLOGY MARKET, 2008 AND 2013 (%)
FIGURE 6 LEADING PRESCRIPTION DRUG REVENUES IN GLOBAL
DERMATOLOGY MARKET, 2008 ($ MILLIONS)
FIGURE 7 ENBREL SALES IN GLOBAL DERMATOLOGY MARKET BY
GEOGRAPHY, 2008 (%, TOTAL REVENUE = $ 3,230 MILLION)
FIGURE 8 BOTOX SALES IN THE GLOBAL DERMATOLOGY MARKET
BY GEOGRAPHY, 2008 (%, TOTAL REVENUE = $ 1,200 MILLION
Dermatological Therapeutics: Global Markets Page 25/28
26. Find Industry reports, Company profiles
ReportLinker and Market Statistics
FIGURE 9 LOCERYL SALES IN GLOBAL DERMATOLOGY MARKET BY
GEOGRAPHY, 2008 (%, TOTAL = $350 MILLION
FIGURE 10 GLOBAL DERMATOLOGICAL PRESCRIPTION MARKET BY
REGIONAL SHARE'FUTURE OUTLOOK, 2011 (%)
FIGURE 11 GLOBAL DERMATOLOGICAL MARKET BY REGIONAL
SHARE, 2008 (%)
FIGURE 12 GLOBAL PRESCRIPTION DERMATOLOGY MARKET SHARE
BY SEGMENT, 2008 (%)
Dermatological Therapeutics: Global Markets Page 26/28
27. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
Dermatological Therapeutics: Global Markets
Product Formats
Please select the product formats and the quantity you require.
Digital Copy--USD 4 850.00 Quantity: _____
Hard Copy--USD 4 850.00 Quantity: _____
Corporate License--USD 8 500.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
Dermatological Therapeutics: Global Markets Page 27/28
28. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Dermatological Therapeutics: Global Markets Page 28/28